Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Henrik Zetterberg

Professor/ chief physician

Henrik Zetterberg
Professor/ chief physician , Avd-/sektionschef, inst
henrik.zetterberg@clinchem.gu.se
+46 31-343 0142
0768-672647

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Blå stråket 5 vån 5 su/sahlgrenska , 41345 Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults
A. V. Idland, R. Sala-Llonch, L. O. Watne, A. Braekhus, O. Hansson et al.
Neurobiology of Aging, Journal article 2020
Journal article

Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
Alberto Benussi, Thomas Karikari, Nicholas J. Ashton, Stefano Gazzina, Enrico Premi et al.
Journal of neurology, neurosurgery, and psychiatry, Journal article 2020
Journal article

Neurofilaments in progressive multiple sclerosis: a systematic review
T. Williams, Henrik Zetterberg, J. Chataway
Journal of Neurology, Journal article 2020
Journal article

Steroid-Responsive Encephalitis in Coronavirus Disease 2019
A. Pilotto, S. Odolini, S. Masciocchi, A. Comelli, I. Volonghi et al.
Annals of Neurology, Journal article 2020
Journal article

Self-reported Sleep Problems Related to Amyloid Deposition in Cortical Regions with High HOMER1 Gene Expression
A. M. Fjell, D. Sederevicius, M. H. Sneve, A. M. G. De Lange, A. C. Brathen et al.
Cerebral Cortex, Journal article 2020
Journal article

Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
C. Meregalli, G. Fumagalli, P. Alberti, A. Canta, A. Chiorazzi et al.
Archives of Toxicology, Journal article 2020
Journal article

A beta deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
N. Mattsson-Carlgren, E. Andersson, S. Janelidze, R. Ossenkoppele, P. Insel et al.
Science Advances, Journal article 2020
Journal article

Longitudinal change in regional brain volumes with exposure to repetitive head impacts.
Charles Bernick, Guogen Shan, Henrik Zetterberg, Sarah Banks, Virendra R Mishra et al.
Neurology, Journal article 2020
Journal article

Showing 21 - 30 of 1226

2020

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
E. H. Thijssen, R. La Joie, A. Wolf, A. Strom, P. Wang et al.
Nature Medicine, Journal article 2020
Journal article

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
Nicholas J. Ashton, Abdul Hye, Anto P Rajkumar, Antoine Leuzy, Stuart Snowden et al.
Nature Reviews Neurology, Review article 2020
Review article

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
Martí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, Kaj Blennow, Anthony Caggiano et al.
Alzheimer's research & therapy, Journal article 2020
Journal article

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.
Marie-Angélique De Scheerder, Clarissa Van Hecke, Henrik Zetterberg, Dietmar Fuchs, Nele De Langhe et al.
The Journal of antimicrobial chemotherapy, Journal article 2020
Journal article

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.
Stephen Mullin, Laura Smith, Katherine Lee, Gayle D'Souza, Philip Woodgate et al.
JAMA neurology, Journal article 2020
Journal article

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia.
Franc Llorens, Peter Hermann, Anna Villar-Piqué, Daniela Diaz-Lucena, Katarina Nägga et al.
Nature communications, Journal article 2020
Journal article

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Sven J van der Lee, Olivia J Conway, Iris Jansen, Minerva M Carrasquillo, Luca Kleineidam et al.
Acta neuropathologica, Journal article 2020
Journal article

Showing 21 - 30 of 1226

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?